| Title |
Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial
|
|---|---|
| Published in |
Clinical Rheumatology, September 2012
|
| DOI | 10.1007/s10067-012-2053-x |
| Pubmed ID | |
| Authors |
Mohammed Kamal Senna, Rehab Abd-El Raouf Sallam, Hala Salah Ashour, Mohammed Elarman |
| Abstract |
The aim of the study was to examine whether weight reduction can result in improvement of fibromyalgia impact questionnaire (FIQ) in the patients with fibromyalgia syndrome (FMS). This study was a randomized controlled trial. Obese patients with fibromyalgia were randomly assigned to 6-month dietary weight loss (n = 41) and no weight loss (n = 42) groups. Patients were assessed at baseline and at 6 months. The primary outcome measure was FIQ. Secondary measures included the tender point (TP) examination, Beck Depression Inventory-II, and Pittsburg Sleep Quality Index. Compared to the control group, patients who underwent weight reduction obtained significantly better FIQ (p = 0.007), lower mean TP count (p = 0.015), and lower mean TP pain rating in the lower body (p < 0.001). Patients who lost weight had less depression and better sleep quality than the controls. Patients who lost weight had significantly lower interleukin 6 and C-reactive protein levels than those in the control group (p = 0.034 and p = 0.007, respectively). Weight loss in obese patients with FMS leads to significant improvement in the quality of life as shown by the decrease in the FIQ score. Depression, sleep quality, and tender point count are also significantly improved by weight loss in obese patients with fibromyalgia. Our results suggest that weight reduction should be a part of fibromyalgia treatment. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 5 | 33% |
| Sweden | 2 | 13% |
| Denmark | 1 | 7% |
| United States | 1 | 7% |
| Unknown | 6 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 73% |
| Scientists | 3 | 20% |
| Practitioners (doctors, other healthcare professionals) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 181 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 178 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 36 | 20% |
| Student > Bachelor | 31 | 17% |
| Researcher | 17 | 9% |
| Other | 13 | 7% |
| Student > Postgraduate | 13 | 7% |
| Other | 33 | 18% |
| Unknown | 38 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 29% |
| Nursing and Health Professions | 32 | 18% |
| Psychology | 20 | 11% |
| Agricultural and Biological Sciences | 6 | 3% |
| Neuroscience | 5 | 3% |
| Other | 24 | 13% |
| Unknown | 42 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2021.
All research outputs
#1,731,625
of 23,577,761 outputs
Outputs from Clinical Rheumatology
#180
of 3,091 outputs
Outputs of similar age
#11,111
of 170,471 outputs
Outputs of similar age from Clinical Rheumatology
#2
of 30 outputs
Altmetric has tracked 23,577,761 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,091 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,471 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.